Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Urgent cash needs can be stressful, but there are ways to access cash quickly. Discover effective strategies to secure funds when you need them.
21,933 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Fresh analyst calls on Tuesday cover a diverse set of names from Blackstone to Qualcomm, signaling continued caution ...
Speculative growth stocks Archer Aviation and Quantum Computing slid after earnings, as burn rates and macro headwind...
As AI expands, the backbone—data centers and compute—becomes a focal point for investors. This guide compares CoreWea...
Citi lifts Celanese's price target to 81 amid rising Iran risk and potential Strait of Hormuz disruption, pointing to...
The S&P 500 has fallen 2.5% this month, but Gabelli Multimedia Trust and Trinity Capital have held steady. Their inco...
Investor nerves rose as here's gemini space station faced a sharp price drop this week. This piece breaks down what s...
Micron Technology rides a surge in AI memory demand, delivering stronger margins and robust cash flow. As the company...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
Choosing between REET and GQRE comes down to how you want exposure to global real estate. This guide breaks down meth...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
In a year of volatile rates, Vanguard’s cheapest short-term bond ETF stands out for ultra-low fees and solid near-ter...